FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| STAQ Pharma Inc | 73177-159 | 73177-159-02 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-159 | 73177-159-03 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-13 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-14 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-26 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-20 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-169 | 73177-169-26 | Sodium Chloride | Sodium Chloride | 9 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-169 | 73177-169-28 | Sodium Chloride | Sodium Chloride | 9 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-116 | 73177-116-02 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-116 | 73177-116-03 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-144 | 73177-144-31 | Theophylline | Theophylline | 1.55 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-145 | 73177-145-31 | Theophylline | Theophylline | 3.1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| STASKA PHARMACEUTICALS, INC. | 80098-030 | 80098-030-90 | ISOSULFAN BLUE | ISOSULFAN BLUE | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-001 | 73217-001-10 | Tacrolimus 0.02% Ophth | Tacrolimus | .2 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-001 | 73217-001-15 | Tacrolimus 0.02% Ophth | Tacrolimus | .2 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-002 | 73217-002-10 | Tacrolimus 0.03% Ophth | Tacrolimus | .3 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-002 | 73217-002-15 | Tacrolimus 0.03% Ophth | Tacrolimus | .3 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-003 | 73217-003-10 | Tacrolimus 0.1% Ophth | Tacrolimus | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-004 | 73217-004-10 | Tacrolimus 0.5% Ophth | Tacrolimus | 5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-005 | 73217-005-10 | Tacrolimus 1% Ophth | Tacrolimus | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 118651212 | 81483-0041 | 81483-0041-5 | Bevacizumab | 1.25 mg/.05 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0045 | 81483-0045-4 | Semaglutide | .25 mg/.05 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0046 | 81483-0046-4 | Semaglutide | .5 mg/.1 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0047 | 81483-0047-4 | Semaglutide | 1 mg/.2 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0049 | 81483-0049-4 | Semaglutide | 2.4 mg/.3 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0048 | 81483-0048-4 | Semaglutide | 1.7 mg/.22 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0050 | 81483-0050-4 | Tirzepatide | 2.4 mg/.1 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0053 | 81483-0053-4 | Tirzepatide | 10 mg/.2 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0052 | 81483-0052-4 | Tirzepatide | 7.5 mg/.3 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0054 | 81483-0054-4 | Tirzepatide | 12.5 mg/.25 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0055 | 81483-0055-4 | Tirzepatide | 15 mg/.3 mL | 2024-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0051 | 81483-0051-4 | Tirzepatide | 5 mg/.2 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0044 | 81483-0044-0 | Albuterol Sulfate | 5 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0035 | 81483-0035-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 5 ug/1 mL; 2.5 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0038 | 81483-0038-0 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 ug/1 mL; 20 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0037 | 81483-0037-0 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 10 ug/1 mL; 10 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0006 | 81483-0006-0 | Ketamine Hydrochloride | 10 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0001 | 81483-0001-0 | Lidocaine Hydrochloride | 20 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 10 mg/1 mL | 2024-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 81483-0044 | 81483-0044-0 | Albuterol Sulfate | Albuterol Sulfate | 5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0041 | 81483-0041-5 | Avastin | Bevacizumab | 1.25 mg/.05 mL | 2024-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0035 | 81483-0035-0 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 5 ug/1 mL; 2.5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0006 | 81483-0006-0 | Ketamine | Ketamine Hydrochloride | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0000 | 81483-0000-0 | LIDOCAINE | LIDOCAINE HYDROCHLORIDE | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0001 | 81483-0001-0 | LIDOCAINE | LIDOCAINE HYDROCHLORIDE | 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0038 | 81483-0038-0 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 5 ug/1 mL; 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0037 | 81483-0037-0 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 10 ug/1 mL; 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0045 | 81483-0045-4 | SEMAGLUTIDE | SEMAGLUTIDE | .25 mg/.05 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0047 | 81483-0047-4 | SEMAGLUTIDE | SEMAGLUTIDE | 1 mg/.2 mL | 2024-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 81483-0048 | 81483-0048-4 | SEMAGLUTIDE | SEMAGLUTIDE | 1.7 mg/.22 mL | 2024-2 | valid | 2026-09-18 |